Interactions of vitamins and gut microbiota in neurodevelopmental disordersBehavioural Brain ResearchIF2.32026-01-100PRE
Discovery of a Highly Selectiveβ2-Adrenoceptor Agonist with a2-Amino-2-phenylethanol Scaffold as an Oral Antiasthmatic AgentJOURNAL OF MEDICINAL CHEMISTRYIF6.82022-04-013PRE
8-Hydroxyquinolin-2(1H)-one analogues as potential β2-agonists: Design, synthesis and activity studyEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92021-11-012PREAI
Heterodimerization With 5-HT2BR Is Indispensable for β2AR-Mediated CardioprotectionCIRCULATION RESEARCHIF16.22021-01-2225OAAI
Recent Advances in β2-Agonists for Treatment of Chronic Respiratory Diseases and Heart FailureJOURNAL OF MEDICINAL CHEMISTRYIF6.82020-11-1911PREAI
Design, synthesis and biological evaluation of 8-(2-amino-1-hydroxyethyl)-6-hydroxy-1,4-benzoxazine-3(4H)-one derivatives as potent β2-adrenoceptor agonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32020-01-018PRE
Design, synthesis and biological evaluation of 5-(2-amino-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one derivatives as potent β2-adrenoceptor agonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32019-06-0112PREAI
Discovery of β-arrestin-biased β2-adrenoceptor agonists from 2-amino-2-phenylethanol derivativesACTA PHARMACOLOGICA SINICAIF8.42019-01-148OAAI
ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failureCELL DISCOVERYIF12.52018-10-2326OAAI
Synthesis and biological evaluation of β2-adrenoceptor agonists bearing the 2-amino-2-phenylethanol scaffoldEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92018-05-0111PREAI
Biased Agonism at the Angiotensin Receptor Blocker and Calcium Sensitizer at the Same TimeCIRCULATIONIF38.62017-03-143OAAI
Vasopressin V1A receptor mediates cell proliferation through GRK2-EGFR-ERK1/2 pathway in A7r5 cellsEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72016-12-0112PREAI
Interaction of β1-adrenoceptor with RAGE mediates cardiomyopathy via CaMKII signalingJCI INSIGHTIF6.12016-01-2124OAAI
Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptorBRITISH JOURNAL OF PHARMACOLOGYIF7.72015-02-278OAAI
Biased 2-adrenoceptor signalling in heart failure: pathophysiology and drug discoveryBRITISH JOURNAL OF PHARMACOLOGYIF7.72014-12-1762OAAI
Tyrosine 308 Is Necessary for Ligand-directed Gs Protein-biased Signaling of β2-AdrenoceptorJOURNAL OF BIOLOGICAL CHEMISTRYIF3.92014-07-0143OAAI
β-Adrenergic receptor subtype signaling in heart: From bench to bedsideACTA PHARMACOLOGICA SINICAIF8.42012-01-30147OA
RGS2 is a primary terminator of β2-adrenergic receptor-mediated Gi signalingJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72011-06-0137OAAI
OUTCOME STUDY OF DRUG ELUTING STENT (DES) VERSUS BARE METAL STENT (BMS) IN HONG KONG: A 6-MONTH PILOT STUDYVALUE IN HEALTHIF62011-05-011OAAI
β2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma CellsJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82011-02-0138OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向